Dar Zavain 4
4 · RECURSION PHARMACEUTICALS, INC. · Filed Jan 4, 2024
Insider Transaction Report
Form 4
Dar Zavain
Director
Transactions
- Award
Class A Common Stock
2024-01-02+1,393→ 55,216 total
Footnotes (1)
- [F1]The shares were issued pursuant to the Issuer's Outside Director Compensation Policy